The TechCrunch List is a verified, curated list of investors who have demonstrated a recent commitment to first checks and leading rounds from seed through growth, organized by market vertical.

Jenny Rooke of Genoa Ventures joins Nick Moran at The Full Ratchet to discuss Seed Investing at the Intersection of Biology & Technology.

March is National Women’s Month with March 8 specifically designated as International Women’s Day. Although this is not remotely a comprehensive list, BioSpace recognizes these 10 women (in no particular order) as being especially influential in the biopharma industry.

Erik is joined by Jenny Rooke (@drjennyrooke), Managing Director at Genoa Ventures, and Jared Seehafer (@seehafer), Village Global Network Leader and CEO and co-founder of Enzyme.

Venture capitalists see a steady stream of people asking for money and currying favor. This can inflate the ego to unhealthy proportions. The best VCs, however, don’t let all that get to their head. They also don’t just write checks. They help entrepreneurs.

We had the opportunity to speak with investor Jenny Rooke, PhD, managing director at 5 Prime Ventures to learn more about careers in synthetic biology outside of research and development.

Here are several barriers to investing in synthetic biology that I’ve observed, drawing on comparisons to biotech investing more generally.